drugset / Trial / NCT03791372
Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy
Non-randomizedParallel-groupSingle-blindTreatment
Summary
To study the clinical efficacy and safety of autologous umbilical cord blood transfusion in the treatment of cerebral palsy.
Timeline
- Start
- 2017-10-10
- Primary completion
- 2020-10-10
- Completion
- 2021-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous cord blood | Cell therapy | 20 ml | Intravenous |
| Subject | Autologous cord blood | Cell therapy | 30 ml | Intravenous |
| Subject | Autologous cord blood | Cell therapy | 1e+07 cells/kg | Intravenous |
Indications
No indication recorded.